Sensyne Health plc announced that it has appointed Michael Norris as Interim Chief Financial Officer, with immediate effect. Michael has more than 20 years' experience working with public and private companies in the technology and life sciences sectors and has overseen a wide range of corporate activities. Michael has a wealth of CFO experience, serving as CFO and Interim CFO for a number of companies including Beckley Canopy Therapeutics, Itaconix, HMR and Rapid Rhythm.